Alterity Therapeutics Highlights New Publications On ATH434 In Parkinson's Disease

By: via Benzinga
Alterity Therapeutics's(NASDAQ: ATHE) data in an animal model of Multiple System Atrophy (MSA) were published in the Journal ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.